Titanium mesh covered with biocompatible polypropylene film for covering and protecting bone grafts/biomaterials and process for obtaining same
US-2024398571-A1 · Dec 5, 2024 · US
US9737395B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9737395-B2 |
| Application number | US-201514751396-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 26, 2015 |
| Priority date | Jun 26, 2015 |
| Publication date | Aug 22, 2017 |
| Grant date | Aug 22, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods are disclosed to protect a medical device from scarring a body after implanting the device in the body by creating a bonding matrix on a surface of the device; exposing the surface to hyaluronic acid (HA) or polyethylene glycol (PEG); cross linking the HA or PEG; and preventing capsular contracture after implanting the device in the body.
Opening claim text (preview).
What is claimed is: 1. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: swelling a device shell; allowing hyaluronic acid (HA) to diffuse into a polymer matrix of the shell; cross-linking the HA while the shell is swollen; and deswelling the device shell thereafter. 2. The method of claim 1 , comprising forming an interpenetrating network with the HA. 3. The method of claim 1 , comprising cross-linking the HA to an iso-osmotic state. 4. The method of claim 1 , comprising swelling the device shell with tetrahydrofuran (THF) or dichloromethane (DCM). 5. The method of claim 1 , comprising deswelling with water or saline. 6. The method of claim 1 , comprising cross-linking the HA with divinyl sulfide (DVS) or diglycidyl ether (BDDE). 7. The method of claim 1 , wherein the device comprises an implantable medical device. 8. The method of claim 1 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 9. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: swelling a device shell; allowing hyaluronic acid (HA) to diffuse into a polymer matrix of the shell; cross-linking the HA while the shell is swollen; and deswelling the device shell thereafter; and preventing capsular contracture after implanting the device in the body. 10. The method of claim 9 , wherein the device comprises an implantable medical device. 11. The method of claim 9 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 12. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: exposing a device surface to hyaluronic acid (HA) or polyethylene glycol (PEG); cross linking the HA or PEG; swelling a device shell; allowing HA or PEG to diffuse into a polymer matrix of the shell; and deswelling the device shell thereafter. 13. The method of claim 12 , wherein the device comprises an implantable medical device. 14. The method of claim 12 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 15. The method of claim 12 , comprising cross-linking the HA while the shell is swollen.
Macromolecular materials · CPC title
Mammary prostheses · CPC title
multilayered, e.g. laminated structures · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Means for introducing or releasing pharmaceutical products into the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.